1. Comparison of clinical and economic burden of pulmonary arterial hypertension patients with and without connective tissue disease treated with macitentan. (3rd October 2022) Authors: Worden, C; Shoaib-Agwan, S; Singh, R; Zhang, W; Panjabi, S Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Persistence with macitentan versus other endothelin receptor antagonists in patients with pulmonary arterial hypertension: experience from a real-world data repository in the USA. (3rd October 2022) Authors: Worden, C; Azam, S; Kouhkamari, M; Caillet, V; Panjabi, S Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗